As of 2025-09-17, the Relative Valuation of Vertex Pharmaceuticals Inc (VRTX) is 137.35 USD. This relative valuation is based on P/E multiples. With the latest stock price at 391.36 USD, the upside of Vertex Pharmaceuticals Inc based on Relative Valuation is -64.9%.
The range of the Relative Valuation is 18.76 - 311.56 USD.
| Range | Selected | |
| Trailing P/E multiples | 16.8x - 22.0x | 17.8x |
| Forward P/E multiples | 16.7x - 21.7x | 19.0x |
| Fair Price | 18.76 - 311.56 | 137.35 |
| Upside | -95.2% - -20.4% | -64.9% |
| Date | P/E |
| 2025-09-16 | 27.58 |
| 2025-09-15 | 27.71 |
| 2025-09-12 | 27.81 |
| 2025-09-11 | 28.01 |
| 2025-09-10 | 27.39 |
| 2025-09-09 | 27.95 |
| 2025-09-08 | 27.86 |
| 2025-09-05 | 27.92 |
| 2025-09-04 | 27.98 |
| 2025-09-03 | 27.96 |
| 2025-09-02 | 28.26 |
| 2025-08-29 | 27.56 |
| 2025-08-28 | 27.63 |
| 2025-08-27 | 27.42 |
| 2025-08-26 | 27.29 |
| 2025-08-25 | 27.41 |
| 2025-08-22 | 27.85 |
| 2025-08-21 | 28.01 |
| 2025-08-20 | 27.80 |
| 2025-08-19 | 27.54 |
| 2025-08-18 | 27.48 |
| 2025-08-15 | 27.69 |
| 2025-08-14 | 27.51 |
| 2025-08-13 | 27.91 |
| 2025-08-12 | 27.33 |
| 2025-08-11 | 26.39 |
| 2025-08-08 | 25.83 |
| 2025-08-07 | 26.48 |
| 2025-08-06 | 27.18 |
| 2025-08-05 | 26.43 |
| 2025-08-04 | 33.29 |
| 2025-08-01 | 32.57 |
| 2025-07-31 | 32.20 |
| 2025-07-30 | 33.07 |
| 2025-07-29 | 33.02 |
| 2025-07-28 | 32.48 |
| 2025-07-25 | 33.10 |
| 2025-07-24 | 33.29 |
| 2025-07-23 | 33.62 |
| 2025-07-22 | 33.14 |
| 2025-07-21 | 32.32 |
| 2025-07-18 | 32.41 |
| 2025-07-17 | 32.65 |
| 2025-07-16 | 33.10 |
| 2025-07-15 | 32.72 |
| 2025-07-14 | 33.29 |
| 2025-07-11 | 33.05 |
| 2025-07-10 | 33.80 |
| 2025-07-09 | 33.76 |
| 2025-07-08 | 32.87 |